dipyridamole
Ligand Summary
A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
UNII: 64ALC7F90C
PubChem: 3108
Guide to Pharmacology: 4807
ChEMBL: CHEMBL932
DrugCentral: 924
LyCHI: JSHXM1LT6W7V
Target Activities
35 Activities
Items per page:
10
1 – 10 of 35
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
- | ||||||
IC50 | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||